CTCBIO Inc. (KOSDAQ:060590)

Market Cap	160.19B
Revenue (ttm)	145.31B
Net Income (ttm)	-4.30B
Shares Out	23.91M
EPS (ttm)	-179.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	285,907
Average Volume	45,227
Open	6,390.00
Previous Close	6,350.00
Day's Range	6,390.00 - 6,980.00
52-Week Range	5,960.00 - 9,210.00
Beta	0.08
RSI	66.10
Earnings Date	Aug 21, 2025

About CTCBIO

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC cov...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1993
• Employees: 245
• Stock Exchange: KOSDAQ
• Ticker Symbol: 060590

Financial Performance

In 2024, CTCBIO's revenue was 144.41 billion, an increase of 4.74% compared to the previous year's 137.88 billion. Losses were -5.22 billion, -66.51% less than in 2023.